Jânio Rodrigo de Jesus Santos, Cláudio Damasceno Pinto, Angela Machado Rocha
{"title":"在寨卡病毒战略中使用纳米生物技术的技术情景","authors":"Jânio Rodrigo de Jesus Santos, Cláudio Damasceno Pinto, Angela Machado Rocha","doi":"10.1080/09737766.2021.1981172","DOIUrl":null,"url":null,"abstract":"Nanobiotechnology is a promising area of research that has been used to develop technologies to combat Zika virus (ZIKV). This study aims to analyze the patent scenario related to the use of nanobiotechnology in strategies against the ZIKV, using the Orbit Intelligence software. The results point to growth in the number of patent deposits between the years 2015 and 2019. Modernatx, MIT, and Harvard University own 38% of the technologies developed against the ZIKV. The EPO, WIPO, and the United States received 47% of patent protection applications developed by companies with support from techniques in the fields of pharmacology and biotechnology. About 42% of patents found belong to the areas of diagnosis and prevention, designed with the aid of nanoparticles used as delivery systems in vaccines and rapid tests. The results showed that nanobiotechnology is an emerging technology and has been widely used in strategies to stop the ZIKV advance.","PeriodicalId":10501,"journal":{"name":"COLLNET Journal of Scientometrics and Information Management","volume":"15 1","pages":"413 - 428"},"PeriodicalIF":1.6000,"publicationDate":"2021-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Technological scenarios of the use of nanobiotechnology in strategies against Zika virus\",\"authors\":\"Jânio Rodrigo de Jesus Santos, Cláudio Damasceno Pinto, Angela Machado Rocha\",\"doi\":\"10.1080/09737766.2021.1981172\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nanobiotechnology is a promising area of research that has been used to develop technologies to combat Zika virus (ZIKV). This study aims to analyze the patent scenario related to the use of nanobiotechnology in strategies against the ZIKV, using the Orbit Intelligence software. The results point to growth in the number of patent deposits between the years 2015 and 2019. Modernatx, MIT, and Harvard University own 38% of the technologies developed against the ZIKV. The EPO, WIPO, and the United States received 47% of patent protection applications developed by companies with support from techniques in the fields of pharmacology and biotechnology. About 42% of patents found belong to the areas of diagnosis and prevention, designed with the aid of nanoparticles used as delivery systems in vaccines and rapid tests. The results showed that nanobiotechnology is an emerging technology and has been widely used in strategies to stop the ZIKV advance.\",\"PeriodicalId\":10501,\"journal\":{\"name\":\"COLLNET Journal of Scientometrics and Information Management\",\"volume\":\"15 1\",\"pages\":\"413 - 428\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2021-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"COLLNET Journal of Scientometrics and Information Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/09737766.2021.1981172\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFORMATION SCIENCE & LIBRARY SCIENCE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"COLLNET Journal of Scientometrics and Information Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/09737766.2021.1981172","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFORMATION SCIENCE & LIBRARY SCIENCE","Score":null,"Total":0}
Technological scenarios of the use of nanobiotechnology in strategies against Zika virus
Nanobiotechnology is a promising area of research that has been used to develop technologies to combat Zika virus (ZIKV). This study aims to analyze the patent scenario related to the use of nanobiotechnology in strategies against the ZIKV, using the Orbit Intelligence software. The results point to growth in the number of patent deposits between the years 2015 and 2019. Modernatx, MIT, and Harvard University own 38% of the technologies developed against the ZIKV. The EPO, WIPO, and the United States received 47% of patent protection applications developed by companies with support from techniques in the fields of pharmacology and biotechnology. About 42% of patents found belong to the areas of diagnosis and prevention, designed with the aid of nanoparticles used as delivery systems in vaccines and rapid tests. The results showed that nanobiotechnology is an emerging technology and has been widely used in strategies to stop the ZIKV advance.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
